Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 4669.52 | 328 / 328 | 100% | 59.89 | 178 / 178 |
thymus | 100% | 11765.30 | 653 / 653 | 100% | 113.99 | 605 / 605 |
uterus | 100% | 11149.16 | 170 / 170 | 100% | 56.42 | 459 / 459 |
kidney | 100% | 6961.64 | 89 / 89 | 100% | 56.36 | 900 / 901 |
brain | 100% | 5745.81 | 2638 / 2642 | 100% | 80.23 | 705 / 705 |
prostate | 100% | 9626.53 | 245 / 245 | 100% | 76.08 | 501 / 502 |
adrenal gland | 100% | 5848.16 | 258 / 258 | 100% | 104.87 | 229 / 230 |
lung | 100% | 7217.74 | 578 / 578 | 99% | 46.56 | 1147 / 1155 |
ovary | 100% | 15378.23 | 180 / 180 | 99% | 44.62 | 427 / 430 |
breast | 100% | 7266.74 | 459 / 459 | 99% | 52.62 | 1110 / 1118 |
skin | 99% | 3632.15 | 1793 / 1809 | 100% | 75.69 | 472 / 472 |
esophagus | 99% | 6158.72 | 1435 / 1445 | 99% | 30.27 | 181 / 183 |
bladder | 100% | 8498.57 | 21 / 21 | 98% | 41.13 | 493 / 504 |
intestine | 100% | 7264.63 | 966 / 966 | 98% | 28.99 | 514 / 527 |
stomach | 100% | 5576.78 | 359 / 359 | 97% | 26.64 | 278 / 286 |
liver | 97% | 2436.58 | 219 / 226 | 99% | 35.51 | 400 / 406 |
blood vessel | 100% | 9802.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 80.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 51.14 | 29 / 29 |
spleen | 100% | 8833.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.95 | 1 / 1 |
adipose | 100% | 6143.08 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 4228.38 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4723.62 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 3795.19 | 828 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0005813 | Cellular component | centrosome |
GO_0035098 | Cellular component | ESC/E(Z) complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0003677 | Molecular function | DNA binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_1990226 | Molecular function | histone methyltransferase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | PHF1 |
Protein name | PHD finger protein 1 (Protein PHF1) (hPHF1) (Polycomb-like protein 1) (hPCl1) PHD finger protein 1 |
Synonyms | PCL1 |
Description | FUNCTION: Polycomb group (PcG) that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex. Involved in DNA damage response and is recruited at double-strand breaks (DSBs). Acts by binding to H3K36me3, a mark for transcriptional activation, and recruiting the PRC2 complex: it is however unclear whether recruitment of the PRC2 complex to H3K36me3 leads to enhance or inhibit H3K27me3 methylation mediated by the PRC2 complex. According to some reports, PRC2 recruitment by PHF1 promotes H3K27me3 and subsequent gene silencing by inducing spreading of PRC2 and H3K27me3 into H3K36me3 loci . According to another report, PHF1 recruits the PRC2 complex at double-strand breaks (DSBs) and inhibits the activity of PRC2 . Regulates p53/TP53 stability and prolonges its turnover: may act by specifically binding to a methylated from of p53/TP53. . |
Accessions | A2AB23 A0A087WVG4 A2AB25 ENST00000454914.6 ENST00000487667.5 ENST00000495509.6 ENST00000423868.1 ENST00000374512.7 [O43189-2] ENST00000427826.1 ENST00000459809.5 A0A140TA01 A2AB22 A0A140TA07 ENST00000427004.5 ENST00000428274.5 E9PQZ5 A0A0G2JIJ9 E9PQT8 ENST00000419154.5 ENST00000495185.5 ENST00000421466.5 O43189 ENST00000427869.6 A0A140T9U3 ENST00000374516.8 [O43189-1] ENST00000447305.5 ENST00000475137.5 |